Overview

CED With Irinotecan Liposome Injection Using Real Time Imaging in Children With Diffuse Intrinsic Pontine Glioma (DIPG) (PNOC 009)

Status:
Completed

Trial end date:
2021-10-04

Target enrollment:

Participant gender:

Summary

This is a Phase I and Early Efficacy Study of Convection Enhanced Delivery (CED) of irinotecan liposome injection (nal-IRI) Using Real Time Imaging with Gadolinium in Children with Diffuse Intrinsic Pontine Glioma who have completed focal radiotherapy

Phase:

Phase 1

Details

Lead Sponsor:

Sabine Mueller, MD, PhD
University of California, San Francisco

Collaborators:

Pacific Pediatric Neuro-Oncology Consortium
The V Foundation for Cancer Research

Treatments:

Camptothecin
Irinotecan